Clinical Trials Browser

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT06120764 2026-05-01

Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting

Phase NA Recruiting

40 enrolled

Neoplasms, Vomiting

NCT07169851 2026-04-22

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Phase 2 Recruiting

204 enrolled

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT07540169 2026-04-20

The Effect of Stress Ball on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer

Phase NA Recruiting

52 enrolled

Gastrointestinal

Fatigue, Stomach Neoplasms, Vomiting

NCT06904235 2026-03-31

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Phase 2 Recruiting

95 enrolled

Nausea, Vomiting

NCT06886451 2026-03-05

Vomiting Prevention in Children With Cancer

Phase NA Recruiting

1,332 enrolled

Neoplasms, Vomiting

NCT06769165 2025-12-11

EMESIS

Phase NA Recruiting

20 enrolled

Nausea, Vomiting

NCT06532734 2025-12-10

Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype

Recruiting

25 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Rumination Syndrome, Anorexia Nervosa, Feeding and Eating Disorders, Barrett Esophagus, Bulimia, Vomiting

NCT07217600 2025-10-20

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy

Phase 4 Recruiting

60 enrolled

Neoplasms, Vomiting

NCT03118986 2025-10-08

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Phase 2 Recruiting

200 enrolled

Nausea, Neoplasms, Vomiting

NCT07038551 2025-07-02

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

Phase 4 Recruiting

120 enrolled

Other

Opioid-Induced Constipation, Constipation, Nausea, Vomiting

NCT06200168 2025-04-02

Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer

Phase 3 Recruiting

370 enrolled

Breast

Breast Neoplasms, Nausea, Vomiting

NCT06726291 2024-12-10

NOEME

Phase 4 Recruiting

84 enrolled

Gynecologic

Nausea, Vomiting, Endometrial Neoplasms

NCT06314906 2024-03-21

Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Phase 3 Recruiting

370 enrolled

Breast

Breast Neoplasms, Nausea, Vomiting

NCT06017284 2023-11-24

PTCA199-5

Phase 3 Recruiting

100 enrolled

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

NCT05690802 2023-01-19

TSEPHCC

Phase NA Recruiting

1,060 enrolled

Nausea, Vomiting

Clinical Trials

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

The Effect of Stress Ball on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Vomiting Prevention in Children With Cancer

EMESIS

Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer

NOEME

Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

PTCA199-5

TSEPHCC